Jennifer Friel Goldstein

Jennifer Friel Goldstein is both the head of Startup Banking for Tech and Healthcare Banking (THCB) as well as the Head of Business Development and Strategic Initiatives for Life Science and Healthcare (LSHC) at Silicon Valley Bank, a division of First Citizens Bank (NASDAQ: FCNCA). In these roles, Ms. Goldstein leverages her 20+ years of experience financing innovation to develop creative capital solutions for SVB's clients, connect VC and industry stakeholders to key business opportunities, and operate a dynamic and complex banking P&L. Since joining SVB in 2012, Ms. Goldstein has held a variety of leadership positions across the bank. She played key roles in developing SVB's biotech practice, supporting the expansion into investment banking, revitalizing the approach to coordinated business development, and most recently, she served as managing partner with venture investing firm SVB Capital, where she launched and led SVB’s first dedicated Life Sciences investment fund. Prior to joining SVB, Ms. Goldstein served as a director on Pfizer's venture capital team where she led investments into life sciences companies, served as a management consultant at Bain & Co., focused on private equity projects across Europe, and held operational and research roles at Chiron, Genelabs, and Genencor. Ms. Goldstein graduated magna cum laude with a bachelor's degree in bioengineering and a master's degree in biotechnology from the University of Pennsylvania. She also holds an MBA from the Wharton School, where she was named a Joseph Wharton Fellow. Her additional director roles include VentureForward, Digitalis Commons, the Women’s Health Innovation Coalition, and the Leukemia & Lymphoma Society of Northern California. She previously served as an independent director and audit committee member for Alexandria Real Estate Equities (NYSE: ARE). Jennifer lives in the Bay Area with her indie-rock husband, their twin teenage children, and their rescue mutt, Kona.